Proteases play a pivotal role in several biological processes, from digestion, cell proliferation, and differentiation to fertility. Deregulation of protease metabolism can result in several pathological conditions (i.e., cancer, neurodegenerative disorders, and others). Therefore, monitoring proteolytic activity in real time could have a fundamental role in the early diagnosis of these diseases. Herein, the main approaches used to develop biosensors for monitoring proteolytic activity are reviewed. A comparison of the advantages and disadvantages of each approach is provided along with a discussion of their importance and promising opportunities for the early diagnosis of severe diseases. This new era of biosensors can be characterized by the ability to control and monitor biological processes, ultimately improving the potential of personalized medicine.
Biosensing in Personalized Medicine: The Emergence of Protease BiomarkersA deep understanding of the individual characteristics of biological processes and precise control of responses and feedback to therapies are essential in a world that is running towards personalized medicine (see Glossary). Recent reports predict that this market will grow at a compound annual growth rate (CAGR) of over 11% from US$92.4 billion dollars in 2017 to US$194.4 billion in 2024 (https://www.researchandmarkets.com/research/n5kqz7/global?w=5), with oncology responsible for 30% of the revenues generated. Biosensors are one of the underlying technologies of personalized medicine, giving support to the highly informed decisions that are critical to obtain better clinical outcomes and to decrease undesired side-effects. Compared with the personalized medicine market, a similar tendency is observed for the biosensors market where growth from US$18.6 billion dollars in 2018 to US$31.5 billion in 2025 (8% CAGR) is expected (https://www.gminsights.com/industry-analysis/biosensors-market).One of the primary goals of a biosensor is to determine the presence/absence or activity of a given biomarker and to correlate these results with pathophysiological conditions. Proteases are emerging as a new category among the wide variety of biomarkers targeted by biosensors due to their key role in health and disease. In this review, we present the main approaches used to measure proteolytic activity in real timefor both in vivo and in vitro applicationsand discuss recent developments in and future possibilities for protease biosensors (Figure 1A).
The Roles and Idiosyncrasies of Proteases: Why Monitor Proteolytic Activity?Proteases are a widely explored research topic as illustrated by more than 487 000 entries registered in PUBMED. However, it was only recently that proteases emerged as an analyte of interest for biosensing [68]. These hydrolytic enzymes (EC 3.4) play a pivotal role in several biological processes, such as digestion, cell proliferation, and differentiation [1], as well as apoptosis [2], coagulation [3], immunity [4], and fertility [5]. The deregulation of protease metabolism can resul...